Thomas James Doyle insider trades
Open-market stock purchases and sales by Thomas James Doyle, SVP, Finance & Accounting at Kura Oncology, Inc, from SEC Form 4 filings since Feb 7, 2022.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jan 27, 2026 | KURA Kura Oncology, Inc | Sold | $9.4K |
| Jan 27, 2026 | KURA Kura Oncology, Inc | Sold | $5.9K |
| Jan 27, 2026 | KURA Kura Oncology, Inc | Sold | $18.8K |
| Jan 27, 2026 | KURA Kura Oncology, Inc | Sold | $7.5K |
| Jan 2, 2026 | KURA Kura Oncology, Inc | Bought (not open market) | — |
| Jan 2, 2026 | KURA Kura Oncology, Inc | Bought (not open market) | — |
| Nov 14, 2025 | KURA Kura Oncology, Inc | Sold | $50.7K |
| Nov 13, 2025 | KURA Kura Oncology, Inc | Bought (not open market) | — |
Companies traded
- KURA Kura Oncology, Inc: 15 sales, last Jan 27, 2026